Module

Advances in HIV/HCV Coinfection

Source: HIV/AIDS Annual Update 2008

Advances in HIV/HCV Coinfection

Faculty:
David L. Thomas, MD, MPH

CME CREDIT INFORMATION

Release Date: 06/04/08

Expiration Date: 06/03/09

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.2 contact hours (0.12 CEUs)

Registered Nurses: 1.2 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss current findings on the natural history of acute and chronic HCV infection in HIV-infected people
Describe predictors of obtaining a sustained virologic response in HIV/HCV-coinfected individuals
Summarize the types of virologic responses a patient may experienced while on hepatitis C therapy and their importance for deciding on future treatment options

Topics covered include:

Introduction
Introduction: Epidemiology
Course of Hepatitis C
Treatment
Conclusions
Summary—Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.